Inflation And COVID Putting Pressure On Europe’s Paracetamol Supply Chain

 
• By David Ridley

Inflation, new COVID-19 waves and delayed cold and flu outbreaks are causing disruption to Europe's paracetamol supply chain, according to an investigation by HBW Insight. Industry is not currently concerned, but regulators, for example in France, are introducing measures to prevent this issue spreading from children's to adult forms of the drug, as well as to ibuprofen-based alternatives.

Europe’s supply of OTC paracetamol suspension products, mainly for children, is coming under strain, according to an investigation by HBW Insight. 

A number of factors, including price inflation – particularly in the cost of raw materials – recent waves of COVID-19 infection and a delayed cold and flu season have raised concerns

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography